Literature DB >> 10363578

Chemopreventive effect of N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, in rat colon carcinogenesis induced by azoxymethane.

N Yoshimi1, M Shimizu, K Matsunaga, Y Yamada, K Fujii, A Hara, H Mori.   

Abstract

Non-steroidal anti-inflammatory drugs (NSAIDs) such as sulindac and indomethacin inhibit colon carcinogenesis, and selective cyclooxygenase (COX)-2 inhibitors are considered to be potential chemopreventive agents without the side effects of usual NSAIDs. We reported that NS-398, N-(2-cyclohexyloxy-4-nitrophenyl)methane sulfonamide, suppressed the formation of preneoplastic lesions, aberrant crypt foci (ACF), induced by azoxymethane (AOM) in a short-term assay of rat colon carcinogenesis. In this study, we examined the effects of long-term NS-398 administration on rat colon carcinogenesis. After three AOM treatments at weekly intervals, a dose of 10 mg/kg of NS-398 in 5% Arabic gum solution was administered by gavage three times per week in group 2 until the termination of the experiment. Rats in group 1 were fed in a basal diet and given 5% Arabic gum solution alone after AOM treatment. At 40 weeks after the first AOM treatment, all rats were killed and the whole intestines including colon were examined. While the incidences of whole intestinal and colon neoplasms in group 1 were 84.6% and 80.8%, respectively, those in group 2 (given NS-398) were 51.9% and 44.4% respectively (P=0.0177 and P=0.0103 by Fisher's exact test, respectively). The multiplicities in group 2 (0.67+/-0.78 and 0.48+/-0.58) were also decreased significantly compared with those (1.39+/-1.10 and 1.08+/-0.74) in group 1 (P<0.01 by Welch's method and P<0.002 by Student's t test, respectively). In immunohistochemistry for proliferative cell nuclear antigen (PCNA), the PCNA-stained cell index (7.40+/-0.5) in group 2 was significantly decreased from that in group 1 (14.03+/-0.82) (P<0.001 by Welch's method). The results suggest that NS-398, a selective COX inhibitor, has a chemopreventive activity against colon carcinogenesis without side-effects such as gastric ulceration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10363578      PMCID: PMC5926081          DOI: 10.1111/j.1349-7006.1999.tb00762.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


non‐steroidal anti‐inflammatory drugs prostaglandin cyclooxygenase aberrant crypt foci azoxymethane proliferative cell nuclear antigen body weight
  47 in total

1.  TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue.

Authors:  D A Kujubu; B S Fletcher; B C Varnum; R W Lim; H R Herschman
Journal:  J Biol Chem       Date:  1991-07-15       Impact factor: 5.157

2.  NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

Authors:  N Futaki; K Yoshikawa; Y Hamasaka; I Arai; S Higuchi; H Iizuka; S Otomo
Journal:  Gen Pharmacol       Date:  1993-01

3.  Low-dose aspirin and incidence of colorectal tumors in a randomized trial.

Authors:  P H Gann; J E Manson; R J Glynn; J E Buring; C H Hennekens
Journal:  J Natl Cancer Inst       Date:  1993-08-04       Impact factor: 13.506

4.  Cell kinetic analysis of the mucosal epithelium and assay of ornithine decarboxylase activity during the process of 1-hydroxyanthraquinone-induced large bowel carcinogenesis in rats.

Authors:  H Mori; Y Mori; T Tanaka; N Yoshimi; S Sugie; T Kawamori; T Narisawa
Journal:  Carcinogenesis       Date:  1992-12       Impact factor: 4.944

5.  Sulindac for polyposis of the colon.

Authors:  W R Waddell; R W Loughry
Journal:  J Surg Oncol       Date:  1983-09       Impact factor: 3.454

6.  The mRNA overexpression of inflammatory enzymes, phospholipase A2 and cyclooxygenase, in the large bowel mucosa and neoplasms of F344 rats treated with naturally occurring carcinogen, 1-hydroxyanthraquinone.

Authors:  N Yoshimi; N Ino; M Suzui; T Tanaka; S Nakashima; M Nakamura; Y Nozawa; H Mori
Journal:  Cancer Lett       Date:  1995-10-20       Impact factor: 8.679

7.  NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.

Authors:  N Futaki; S Takahashi; M Yokoyama; I Arai; S Higuchi; S Otomo
Journal:  Prostaglandins       Date:  1994-01

8.  Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.

Authors:  E Okajima; A Denda; S Ozono; M Takahama; H Akai; Y Sasaki; W Kitayama; K Wakabayashi; Y Konishi
Journal:  Cancer Res       Date:  1998-07-15       Impact factor: 12.701

9.  Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors.

Authors:  R N DuBois; A Radhika; B S Reddy; A J Entingh
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

10.  Inhibitory effect of NS-398, a selective cyclooxygenase-2 inhibitor, on azoxymethane-induced aberrant crypt foci in colon carcinogenesis of F344 rats.

Authors:  N Yoshimi; K Kawabata; A Hara; K Matsunaga; Y Yamada; H Mori
Journal:  Jpn J Cancer Res       Date:  1997-11
View more
  6 in total

1.  Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation.

Authors:  W A Brown; S A Skinner; C Malcontenti-Wilson; D Vogiagis; P E O'Brien
Journal:  Gut       Date:  2001-05       Impact factor: 23.059

2.  Dietary-feeding of grape seed extract prevents azoxymethane-induced colonic aberrant crypt foci formation in fischer 344 rats.

Authors:  Balaiya Velmurugan; Rana P Singh; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2010-07       Impact factor: 4.784

3.  Effect of indomethacin on cell cycle proteins in colon cancer cell lines.

Authors:  Mei-Hua Xu; Gui-Ying Zhang
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

4.  Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway.

Authors:  Pandurangan Ashokkumar; Ganapasam Sudhandiran
Journal:  Invest New Drugs       Date:  2009-12-15       Impact factor: 3.850

5.  Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer.

Authors:  M Yao; E C Lam; C R Kelly; W Zhou; M M Wolfe
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640

6.  Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.

Authors:  Y Yamada; N Yoshimi; Y Hirose; A Hara; M Shimizu; T Kuno; M Katayama; Z Qiao; H Mori
Journal:  Jpn J Cancer Res       Date:  2001-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.